HighVista Strategies’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-21,519	Closed	-$512K	–	156
2024 Q1	$512K	Buy	+21,519	New	+$480K	0.18%	117
2023 Q4	–	Sell	-29,490	Closed	-$428K	–	144
2023 Q3	$428K	Sell	29,490 -4,086	-12%	-$77.3K	0.2%	122
2023 Q2	$703K	Buy	33,576 +7,972	+31%	+$166K	0.32%	87
2023 Q1	$541K	Buy	25,604 +6,943	+37%	+$173K	0.44%	71
2022 Q4	$475K	Sell	18,661 -18,443	-50%	-$430K	0.28%	76
2022 Q3	$892K	Buy	+37,104	New	+$832K	0.51%	46
2022 Q1	–	Sell	-38,347	Closed	-$839K	–	97
2021 Q4	$839K	Sell	38,347 -7,237	-16%	-$134K	0.67%	55
2021 Q3	$872K	Sell	45,584 -2,230	-5%	-$37.2K	0.58%	58
2021 Q2	$821K	Buy	47,814 +12,941	+37%	+$237K	0.58%	37
2021 Q1	$779K	Buy	+34,873	New	+$788K	0.58%	31